APO Research
Talk to an analyst

APO RESEARCH · REPORT

Viral Detection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Viral Detection Market Outlook and Growth Opportunities 2026

2 May 2026195 pages

Choose your research edition.

Industry ResearchViral Detection Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Viral Detection Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Viral Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Viral Detection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Viral Detection Market Analysis and Forecast 2026-2032240 pages · $4,950 USD

Market perspective

The global Viral Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Viral Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Viral Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Viral Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Viral Detection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Viral Detection market include Merck KGaA, Charles River Laboratories, Eurofins, SGS, Sartorius, Asahi Kasei, Samsung Biologics, Syngene and Intertek, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Viral Detection market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Viral Detection and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Viral Detection revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Viral Detection market.

Viral Detection Segment by Company

Merck KGaA

Charles River Laboratories

Eurofins

SGS

Sartorius

Asahi Kasei

Samsung Biologics

Syngene

Intertek

Minaris Advanced Therapies

Texcell

PathoQuest

Clean Cells

Avance Biosciences

Microbiologics

Alcami

Creative Biolabs

Creative Biogene

WuXi AppTec

WuXi Biologics

Viral Detection Segment by Type

Plaque Assays

PCR

ELISA

Others

Viral Detection Segment by Application

Blood & Blood Products

Cellular & Gene Therapy Products

Stem Cell Products

Tissue & Tissue Products

Vaccines and Therapeutics

Viral Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Viral Detection status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Viral Detection key companies, revenue, market share, and recent developments.

3. To split the Viral Detection breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Viral Detection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Viral Detection significant trends, drivers, influence factors in global and regions.

6. To analyze Viral Detection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Viral Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Viral Detection industry.

Chapter 3: Detailed analysis of Viral Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Viral Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Viral Detection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Viral Detection Industry Trends Table 2. Viral Detection Industry Drivers Table 3. Viral Detection Industry Opportunities and Challenges Table 4. Viral Detection Industry Restraints Table 5. Global Viral Detection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Viral Detection Revenue Share by Company (2021-2026) Table 7. Global Viral Detection Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Viral Detection Key Company Manufacturing Base & Headquarters Table 9. Global Viral Detection Company, Product Type & Application Table 10. Global Viral Detection Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Viral Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Plaque Assays Table 15. Significant Companies of PCR Table 16. Significant Companies of ELISA Table 17. Significant Companies of Others Table 18. Global Viral Detection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Viral Detection Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Viral Detection Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Viral Detection Sales Value Share by Type (2021-2026) Table 22. Global Viral Detection Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Blood & Blood Products Table 24. Significant Companies of Cellular & Gene Therapy Products Table 25. Significant Companies of Stem Cell Products Table 26. Significant Companies of Tissue & Tissue Products Table 27. Significant Companies of Vaccines and Therapeutics Table 28. Global Viral Detection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Viral Detection Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Viral Detection Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Viral Detection Sales Value Share by Application (2021-2026) Table 32. Global Viral Detection Sales Value Share by Application (2027-2032) Table 33. Global Viral Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Viral Detection Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Viral Detection Sales Value Share by Region (2021-2026) Table 36. Global Viral Detection Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Viral Detection Sales Value Share by Region (2027-2032) Table 38. Global Viral Detection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Viral Detection Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Viral Detection Sales Value Market Share by Country (2021-2026) Table 41. Global Viral Detection Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Viral Detection Sales Value Market Share by Country (2027-2032) Table 43. Merck KGaA Company Information Table 44. Merck KGaA Business Overview Table 45. Merck KGaA Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Merck KGaA Viral Detection Product Portfolio Table 47. Merck KGaA Recent Development Table 48. Charles River Laboratories Company Information Table 49. Charles River Laboratories Business Overview Table 50. Charles River Laboratories Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Charles River Laboratories Viral Detection Product Portfolio Table 52. Charles River Laboratories Recent Development Table 53. Eurofins Company Information Table 54. Eurofins Business Overview Table 55. Eurofins Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Eurofins Viral Detection Product Portfolio Table 57. Eurofins Recent Development Table 58. SGS Company Information Table 59. SGS Business Overview Table 60. SGS Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. SGS Viral Detection Product Portfolio Table 62. SGS Recent Development Table 63. Sartorius Company Information Table 64. Sartorius Business Overview Table 65. Sartorius Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sartorius Viral Detection Product Portfolio Table 67. Sartorius Recent Development Table 68. Asahi Kasei Company Information Table 69. Asahi Kasei Business Overview Table 70. Asahi Kasei Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Asahi Kasei Viral Detection Product Portfolio Table 72. Asahi Kasei Recent Development Table 73. Samsung Biologics Company Information Table 74. Samsung Biologics Business Overview Table 75. Samsung Biologics Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Samsung Biologics Viral Detection Product Portfolio Table 77. Samsung Biologics Recent Development Table 78. Syngene Company Information Table 79. Syngene Business Overview Table 80. Syngene Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Syngene Viral Detection Product Portfolio Table 82. Syngene Recent Development Table 83. Intertek Company Information Table 84. Intertek Business Overview Table 85. Intertek Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Intertek Viral Detection Product Portfolio Table 87. Intertek Recent Development Table 88. Minaris Advanced Therapies Company Information Table 89. Minaris Advanced Therapies Business Overview Table 90. Minaris Advanced Therapies Viral Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Minaris Advanced Therapies Viral Detection Product Portfolio Table 92. Minaris Advanced Therapies Recent Development Table 93. Texcell Company Information Table 94. Texcell Business Overview Table 95. Texcell Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Texcell Viral Detection Product Portfolio Table 97. Texcell Recent Development Table 98. PathoQuest Company Information Table 99. PathoQuest Business Overview Table 100. PathoQuest Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. PathoQuest Viral Detection Product Portfolio Table 102. PathoQuest Recent Development Table 103. Clean Cells Company Information Table 104. Clean Cells Business Overview Table 105. Clean Cells Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Clean Cells Viral Detection Product Portfolio Table 107. Clean Cells Recent Development Table 108. Avance Biosciences Company Information Table 109. Avance Biosciences Business Overview Table 110. Avance Biosciences Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Avance Biosciences Viral Detection Product Portfolio Table 112. Avance Biosciences Recent Development Table 113. Microbiologics Company Information Table 114. Microbiologics Business Overview Table 115. Microbiologics Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Microbiologics Viral Detection Product Portfolio Table 117. Microbiologics Recent Development Table 118. Alcami Company Information Table 119. Alcami Business Overview Table 120. Alcami Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Alcami Viral Detection Product Portfolio Table 122. Alcami Recent Development Table 123. Creative Biolabs Company Information Table 124. Creative Biolabs Business Overview Table 125. Creative Biolabs Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Creative Biolabs Viral Detection Product Portfolio Table 127. Creative Biolabs Recent Development Table 128. Creative Biogene Company Information Table 129. Creative Biogene Business Overview Table 130. Creative Biogene Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Creative Biogene Viral Detection Product Portfolio Table 132. Creative Biogene Recent Development Table 133. WuXi AppTec Company Information Table 134. WuXi AppTec Business Overview Table 135. WuXi AppTec Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. WuXi AppTec Viral Detection Product Portfolio Table 137. WuXi AppTec Recent Development Table 138. WuXi Biologics Company Information Table 139. WuXi Biologics Business Overview Table 140. WuXi Biologics Viral Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. WuXi Biologics Viral Detection Product Portfolio Table 142. WuXi Biologics Recent Development Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Viral Detection Product Image Figure 2. Global Viral Detection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Viral Detection Market Size (2021-2032) & (US$ Million) Figure 4. Global Viral Detection Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Plaque Assays Image Figure 8. PCR Image Figure 9. ELISA Image Figure 10. Others Image Figure 11. Global Viral Detection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Viral Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Viral Detection Sales Value Share by Type (2021-2032) Figure 14. Blood & Blood Products Image Figure 15. Cellular & Gene Therapy Products Image Figure 16. Stem Cell Products Image Figure 17. Tissue & Tissue Products Image Figure 18. Vaccines and Therapeutics Image Figure 19. Global Viral Detection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Viral Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Viral Detection Sales Value Share by Application (2021-2032) Figure 22. Global Viral Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Viral Detection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Viral Detection Sales Value (2021-2032) & (US$ Million) Figure 25. North America Viral Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Viral Detection Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Viral Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Viral Detection Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Viral Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Viral Detection Sales Value (2021-2032) & (US$ Million) Figure 31. South America Viral Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Viral Detection Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Viral Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Viral Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Viral Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Viral Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Plaque Assays
  • PCR
  • ELISA
  • Others
Applications
  • Blood & Blood Products
  • Cellular & Gene Therapy Products
  • Stem Cell Products
  • Tissue & Tissue Products
  • Vaccines and Therapeutics
Companies covered
  • Merck KGaA
  • Charles River Laboratories
  • Eurofins
  • SGS
  • Sartorius
  • Asahi Kasei
  • Samsung Biologics
  • Syngene
  • Intertek
  • Minaris Advanced Therapies
  • Texcell
  • PathoQuest
  • Clean Cells
  • Avance Biosciences
  • Microbiologics
  • Alcami
  • Creative Biolabs
  • Creative Biogene
  • WuXi AppTec
  • WuXi Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Viral Detection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Viral Detection Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Viral Detection Market Dynamics
  1. 2.1 Viral Detection Industry Trends
  2. 2.2 Viral Detection Industry Drivers
  3. 2.3 Viral Detection Industry Opportunities and Challenges
  4. 2.4 Viral Detection Industry Restraints
3 Viral Detection Market by Company
  1. 3.1 Global Viral Detection Company Revenue Ranking in 2025
  2. 3.2 Global Viral Detection Revenue by Company (2021-2026)
  3. 3.3 Global Viral Detection Company Ranking (2024-2026)
  4. 3.4 Global Viral Detection Company Manufacturing Base and Headquarters
  5. 3.5 Global Viral Detection Company Product Type and Application
  6. 3.6 Global Viral Detection Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Viral Detection Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Viral Detection Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Viral Detection Market by Type
  1. 4.1 Viral Detection Type Introduction
  2. 4.1.1 Plaque Assays
  3. 4.1.2 PCR
  4. 4.1.3 ELISA
  5. 4.1.4 Others
  6. 4.2 Global Viral Detection Sales Value by Type
  7. 4.2.1 Global Viral Detection Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Viral Detection Sales Value by Type (2021-2032)
  9. 4.2.3 Global Viral Detection Sales Value Share by Type (2021-2032)
5 Viral Detection Market by Application
  1. 5.1 Viral Detection Application Introduction
  2. 5.1.1 Blood & Blood Products
  3. 5.1.2 Cellular & Gene Therapy Products
  4. 5.1.3 Stem Cell Products
  5. 5.1.4 Tissue & Tissue Products
  6. 5.1.5 Vaccines and Therapeutics
  7. 5.2 Global Viral Detection Sales Value by Application
  8. 5.2.1 Global Viral Detection Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Viral Detection Sales Value by Application (2021-2032)
  10. 5.2.3 Global Viral Detection Sales Value Share by Application (2021-2032)
6 Viral Detection Regional Value Analysis
  1. 6.1 Global Viral Detection Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Viral Detection Sales Value by Region (2021-2032)
  3. 6.2.1 Global Viral Detection Sales Value by Region: 2021-2026
  4. 6.2.2 Global Viral Detection Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Viral Detection Sales Value (2021-2032)
  7. 6.3.2 North America Viral Detection Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Viral Detection Sales Value (2021-2032)
  10. 6.4.2 Europe Viral Detection Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Viral Detection Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Viral Detection Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Viral Detection Sales Value (2021-2032)
  16. 6.6.2 South America Viral Detection Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Viral Detection Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Viral Detection Sales Value Share by Country, 2025 VS 2032
7 Viral Detection Country-level Value Analysis
  1. 7.1 Global Viral Detection Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Viral Detection Sales Value by Country (2021-2032)
  3. 7.2.1 Global Viral Detection Sales Value by Country (2021-2026)
  4. 7.2.2 Global Viral Detection Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Viral Detection Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Viral Detection Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Viral Detection Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Viral Detection Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Viral Detection Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Viral Detection Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Viral Detection Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Viral Detection Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Viral Detection Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Viral Detection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Viral Detection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Viral Detection Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Viral Detection Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Viral Detection Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Viral Detection Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Viral Detection Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Viral Detection Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Viral Detection Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Viral Detection Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Viral Detection Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Viral Detection Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Viral Detection Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Viral Detection Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Viral Detection Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Viral Detection Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Viral Detection Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Viral Detection Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Viral Detection Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Viral Detection Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Viral Detection Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Viral Detection Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Viral Detection Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Viral Detection Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Viral Detection Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Viral Detection Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Viral Detection Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Viral Detection Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Viral Detection Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Viral Detection Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Viral Detection Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Viral Detection Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Viral Detection Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Viral Detection Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Viral Detection Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Viral Detection Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Viral Detection Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Viral Detection Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Viral Detection Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Viral Detection Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Viral Detection Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Viral Detection Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Viral Detection Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Viral Detection Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Viral Detection Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Viral Detection Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Viral Detection Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Viral Detection Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Viral Detection Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Viral Detection Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Viral Detection Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Viral Detection Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Viral Detection Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Viral Detection Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Viral Detection Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Viral Detection Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Viral Detection Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Viral Detection Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Viral Detection Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Viral Detection Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Viral Detection Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Viral Detection Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Viral Detection Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Viral Detection Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Viral Detection Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Viral Detection Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Viral Detection Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Viral Detection Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Viral Detection Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Viral Detection Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Viral Detection Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Viral Detection Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Viral Detection Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Viral Detection Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Viral Detection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck KGaA
  2. 8.1.1 Merck KGaA Company Information
  3. 8.1.2 Merck KGaA Business Overview
  4. 8.1.3 Merck KGaA Viral Detection Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck KGaA Viral Detection Product Portfolio
  6. 8.1.5 Merck KGaA Recent Developments
  7. 8.2 Charles River Laboratories
  8. 8.2.1 Charles River Laboratories Company Information
  9. 8.2.2 Charles River Laboratories Business Overview
  10. 8.2.3 Charles River Laboratories Viral Detection Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Charles River Laboratories Viral Detection Product Portfolio
  12. 8.2.5 Charles River Laboratories Recent Developments
  13. 8.3 Eurofins
  14. 8.3.1 Eurofins Company Information
  15. 8.3.2 Eurofins Business Overview
  16. 8.3.3 Eurofins Viral Detection Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Viral Detection Product Portfolio
  18. 8.3.5 Eurofins Recent Developments
  19. 8.4 SGS
  20. 8.4.1 SGS Company Information
  21. 8.4.2 SGS Business Overview
  22. 8.4.3 SGS Viral Detection Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SGS Viral Detection Product Portfolio
  24. 8.4.5 SGS Recent Developments
  25. 8.5 Sartorius
  26. 8.5.1 Sartorius Company Information
  27. 8.5.2 Sartorius Business Overview
  28. 8.5.3 Sartorius Viral Detection Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sartorius Viral Detection Product Portfolio
  30. 8.5.5 Sartorius Recent Developments
  31. 8.6 Asahi Kasei
  32. 8.6.1 Asahi Kasei Company Information
  33. 8.6.2 Asahi Kasei Business Overview
  34. 8.6.3 Asahi Kasei Viral Detection Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Asahi Kasei Viral Detection Product Portfolio
  36. 8.6.5 Asahi Kasei Recent Developments
  37. 8.7 Samsung Biologics
  38. 8.7.1 Samsung Biologics Company Information
  39. 8.7.2 Samsung Biologics Business Overview
  40. 8.7.3 Samsung Biologics Viral Detection Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Samsung Biologics Viral Detection Product Portfolio
  42. 8.7.5 Samsung Biologics Recent Developments
  43. 8.8 Syngene
  44. 8.8.1 Syngene Company Information
  45. 8.8.2 Syngene Business Overview
  46. 8.8.3 Syngene Viral Detection Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Syngene Viral Detection Product Portfolio
  48. 8.8.5 Syngene Recent Developments
  49. 8.9 Intertek
  50. 8.9.1 Intertek Company Information
  51. 8.9.2 Intertek Business Overview
  52. 8.9.3 Intertek Viral Detection Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Intertek Viral Detection Product Portfolio
  54. 8.9.5 Intertek Recent Developments
  55. 8.10 Minaris Advanced Therapies
  56. 8.10.1 Minaris Advanced Therapies Company Information
  57. 8.10.2 Minaris Advanced Therapies Business Overview
  58. 8.10.3 Minaris Advanced Therapies Viral Detection Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Minaris Advanced Therapies Viral Detection Product Portfolio
  60. 8.10.5 Minaris Advanced Therapies Recent Developments
  61. 8.11 Texcell
  62. 8.11.1 Texcell Company Information
  63. 8.11.2 Texcell Business Overview
  64. 8.11.3 Texcell Viral Detection Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Texcell Viral Detection Product Portfolio
  66. 8.11.5 Texcell Recent Developments
  67. 8.12 PathoQuest
  68. 8.12.1 PathoQuest Company Information
  69. 8.12.2 PathoQuest Business Overview
  70. 8.12.3 PathoQuest Viral Detection Revenue and Gross Margin (2021-2026)
  71. 8.12.4 PathoQuest Viral Detection Product Portfolio
  72. 8.12.5 PathoQuest Recent Developments
  73. 8.13 Clean Cells
  74. 8.13.1 Clean Cells Company Information
  75. 8.13.2 Clean Cells Business Overview
  76. 8.13.3 Clean Cells Viral Detection Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Clean Cells Viral Detection Product Portfolio
  78. 8.13.5 Clean Cells Recent Developments
  79. 8.14 Avance Biosciences
  80. 8.14.1 Avance Biosciences Company Information
  81. 8.14.2 Avance Biosciences Business Overview
  82. 8.14.3 Avance Biosciences Viral Detection Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Avance Biosciences Viral Detection Product Portfolio
  84. 8.14.5 Avance Biosciences Recent Developments
  85. 8.15 Microbiologics
  86. 8.15.1 Microbiologics Company Information
  87. 8.15.2 Microbiologics Business Overview
  88. 8.15.3 Microbiologics Viral Detection Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Microbiologics Viral Detection Product Portfolio
  90. 8.15.5 Microbiologics Recent Developments
  91. 8.16 Alcami
  92. 8.16.1 Alcami Company Information
  93. 8.16.2 Alcami Business Overview
  94. 8.16.3 Alcami Viral Detection Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Alcami Viral Detection Product Portfolio
  96. 8.16.5 Alcami Recent Developments
  97. 8.17 Creative Biolabs
  98. 8.17.1 Creative Biolabs Company Information
  99. 8.17.2 Creative Biolabs Business Overview
  100. 8.17.3 Creative Biolabs Viral Detection Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Creative Biolabs Viral Detection Product Portfolio
  102. 8.17.5 Creative Biolabs Recent Developments
  103. 8.18 Creative Biogene
  104. 8.18.1 Creative Biogene Company Information
  105. 8.18.2 Creative Biogene Business Overview
  106. 8.18.3 Creative Biogene Viral Detection Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Creative Biogene Viral Detection Product Portfolio
  108. 8.18.5 Creative Biogene Recent Developments
  109. 8.19 WuXi AppTec
  110. 8.19.1 WuXi AppTec Company Information
  111. 8.19.2 WuXi AppTec Business Overview
  112. 8.19.3 WuXi AppTec Viral Detection Revenue and Gross Margin (2021-2026)
  113. 8.19.4 WuXi AppTec Viral Detection Product Portfolio
  114. 8.19.5 WuXi AppTec Recent Developments
  115. 8.20 WuXi Biologics
  116. 8.20.1 WuXi Biologics Company Information
  117. 8.20.2 WuXi Biologics Business Overview
  118. 8.20.3 WuXi Biologics Viral Detection Revenue and Gross Margin (2021-2026)
  119. 8.20.4 WuXi Biologics Viral Detection Product Portfolio
  120. 8.20.5 WuXi Biologics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst